NCT05772091View on ClinicalTrials.gov

Prognostic Value of Echocardiographic Parameters Based on Machine Learning Approach

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

September 29, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Transthyretin Cardiac Amyloidosis
Trial Locations (4)

Unknown

NOT_YET_RECRUITING

Hôpitaux Universitaires Henri Mondor, Créteil

RECRUITING

CHRU de Nancy, Nancy

NOT_YET_RECRUITING

CHU de Rennes Hôpital Pontchaillou, Rennes

NOT_YET_RECRUITING

CHU de Toulouse, Toulouse

All Listed Sponsors
lead

Pr. Nicolas GIRERD

OTHER